The Houston-based Empower Pharmacy is seeking to dismiss a lawsuit that targets its ability to sell popular diabetes and ...

A Houston-based compounding pharmacy has fired back against a lawsuit filed by the pharmaceutical giant that makes Mounjaro ...

Global pharmaceutical giant Eli Lilly & Co. is considering a $5.9 billion plant in northeast Houston, a potential economic jolt that could accelerate the city's ambitions to become a national hub ...

Houston-based Empower Pharmacy is one of two compounding pharmacies sued by the pharmaceutical giant Eli Lilly earlier this month for allegedly selling "knockoff" versions of its weight loss and ...

Big Pharma has put a Houston pharmacy squarely in the crosshairs of its quest to weed out copycat versions of wildly popular diabetes and weight loss drugs. Eli Lilly, the maker of the diabetes ...

A major pharmaceutical manufacturing company is considering planting ground in Houston, with a $5.7 billion proposed investment into a new facility. Eli Lilly applied for a tax abatement under ...

HOUSTON — Eli Lilly & Co. (NYSE: LLY), one of the largest pharmaceutical manufacturers in the world, could be the latest major manufacturer moving into Houston. The Indianapolis-based drugmaker ...

Eli Lilly's potential Houston expansion could bring thousands of jobs and billions of dollars in investment to the area. Here's where the plant might be built ...

Eli Lilly and Co. is considering Houston as a location for one of its four planned new U.S. manufacturing sites, with the Texas city potentially landing a $5.9 billion facility that could employ ...

Eli Lilly was already in negotiations “with several states” at the time of that announcement and invited additional interest. Despite the tax incentive application, the Houston project isn't ...